Role of the Expression Level of Nrf2 in Predicting Response of EGFR-TKIs 
in Lung Adenocarcinoma Patients with EGFR Gene Mutations

Role of the Expression Level of Nrf2 in Predicting Response of EGFR-TKIs 
in Lung Adenocarcinoma Patients with EGFR Gene Mutations

Background and objective Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have become first-line treatment drugs for lung adenocarcinoma patients with EGFR gene mutations. Significant interindividual variations in response rate, progression-free survival (PFS), and overall sur...

Full description

Bibliographic Details
Main Authors: Xiang ZHU, Li LIANG, Chen LIU, Wencheng YIN, Sen CHEN, Baoshan CAO
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
EGFR
EGFR-TKIs
Nrf2
Survival time
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.02.15

Similar Items

Similar Items